Market Scope's first-edition "2025 Presbyopia Survey Report" provides pivotal insights into treatment methods, adoption plans, average pricing, and emerging technologies shaping the presbyopia landscape. From drops to presbyopia-correcting IOLs, this report delivers survey data essential for informed decision-making in ophthalmic care. Whether you're a healthcare provider, researcher, or investor, leverage this report to navigate the evolving presbyopia market with confidence.
Contents:
Based on extensive global survey data from ophthalmic professionals, this report provides deep insights across surgical, pharmaceutical, and optical presbyopia correction options.
Key highlights include:
Treatment Preferences: Analysis of primary presbyopia management strategies, including surgical, pharmaceutical, and optical options.
IOL Market Dynamics: Trends in average manufacturer pricing, market share by brand, and future adoption plans for post-op adjustable and intermediate-optimized IOLs.
Refractive Surgery Insights: Monovision selection rates, per-eye fees for LVC procedures targeting presbyopia, and volume expectations for 2025.
Pharmaceutical Developments: Patient demographics and prescribing trends for drops like Vuity and Qlosi, plus awareness and adoption projections for upcoming therapies from Lenz Therapeutics and Tenpoint Therapeutics.
Optical Market Overview: Share of vision correction across glasses, readers, and contacts-plus brand market share, replacement schedules, and frequency of purchases.
Decision Drivers: What drives-or delays-adoption of new drops, lenses, and surgical technologies in real-world practice.
(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀ̼Ç02-2025-2992kr-info@giikorea.co.kr ¨Ï Copyright Global Information, Inc. All rights reserved.